Pages that link to "Q28283494"

The following pages link to History of the discovery of the antipsychotic dopamine D2 receptor: a basis for the dopamine hypothesis of schizophrenia (Q28283494):

Displayed 30 items.

• Update on schizophrenia and bipolar disorder: focus on cariprazine (Q26741533) ‎ (← links)
• What does schizophrenia teach us about antipsychotics? (Q26823906) ‎ (← links)
• Antipsychotic dosing: found in translation (Q26863343) ‎ (← links)
• The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue (Q30437188) ‎ (← links)
• Water Extract of Fructus Hordei Germinatus Shows Antihyperprolactinemia Activity via Dopamine D2 Receptor (Q34182721) ‎ (← links)
• Is schizophrenia a dopamine supersensitivity psychotic reaction? (Q34377871) ‎ (← links)
• Domperidone as an unintended antipsychotic (Q34411626) ‎ (← links)
• Olanzapine induced DNA methylation changes support the dopamine hypothesis of psychosis (Q34470248) ‎ (← links)
• Novel Analogues of (R)-5-(Methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (Sumanirole) Provide Clues to Dopamine D2/D3 Receptor Agonist Selectivity (Q37025051) ‎ (← links)
• Clozapine, a fast-off-D2 antipsychotic (Q38161938) ‎ (← links)
• Genetics of antipsychotic-induced weight gain: update and current perspectives (Q38166456) ‎ (← links)
• Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials (Q38545655) ‎ (← links)
• Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds (Q38656262) ‎ (← links)
• Cariprazine for the Treatment of Bipolar Disorder (Q38802226) ‎ (← links)
• New Concepts in Dopamine D2 Receptor Biased Signaling and Implications for Schizophrenia Therapy (Q39004795) ‎ (← links)
• Molecular mechanisms underlying noncoding risk variations in psychiatric genetic studies (Q39043771) ‎ (← links)
• Positive Traits in the Bipolar Spectrum: The Space between Madness and Genius (Q39170724) ‎ (← links)
• Potential drug targets and treatment of schizophrenia (Q39206300) ‎ (← links)
• Insights into the origin of DNA methylation differences between monozygotic twins discordant for schizophrenia. (Q41549683) ‎ (← links)
• Potential link between genetic polymorphisms of catechol-O-methyltransferase and dopamine receptors and treatment efficacy of risperidone on schizophrenia (Q47139082) ‎ (← links)
• Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D2 Receptor (D2R) Biased Agonism (Q48116846) ‎ (← links)
• Motor system dysfunction in the schizophrenia diathesis: Neural systems to neurotransmitters (Q48228571) ‎ (← links)
• Mitochondrial Dysfunction in Schizophrenia: Determination of Mitochondrial Respiratory Activity in a Two-Hit Mouse Model. (Q50534987) ‎ (← links)
• Preclinical Effects of Antipsychotic Drugs. (Q53779310) ‎ (← links)
• Novel and Potent Dopamine D Receptor Go-Protein Biased Agonists (Q61817695) ‎ (← links)
• A Complete Assessment of Dopamine Receptor- Ligand Interactions through Computational Methods (Q64114044) ‎ (← links)
• Mediation of dopamine D2 receptors activation in post-conditioning-attenuated cardiomyocyte apoptosis (Q87074288) ‎ (← links)
• Haloperidol and delirium in the ICU: the finger pointing to the moon (Q89220130) ‎ (← links)
• Schizophrenia: An Overview (Q92897548) ‎ (← links)
• Structure of a D2 dopamine receptor-G-protein complex in a lipid membrane (Q96302945) ‎ (← links)